Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Local Coverage Determinations (LCDs) Finalized - Effective September 22, 2024 Aug 08, 2024
Billing and Coding: MolDX: Afirma™ Assay by Veracyte (A54356) Retirement - Effective July 28, 2024 Aug 01, 2024
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R6 - Effective August 1, 2024 Aug 01, 2024
Billing and Coding MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R19 - Effective August 1, 2024 Aug 01, 2024
MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms - Published for Review and Comments Aug 01, 2024